These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Subacute-cutaneous lupus erythematosus induced by Simvastatin. RĂ¼ger RD; Simon JC; Treudler R J Dtsch Dermatol Ges; 2011 Jan; 9(1):54-5. PubMed ID: 21040470 [No Abstract] [Full Text] [Related]
49. [CME. Severe cutaneous drug reaction]. Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114 [No Abstract] [Full Text] [Related]
50. Immunohistochemical characterization of cutaneous drug eruptions by STI571. Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119 [TBL] [Abstract][Full Text] [Related]
52. Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases. Seneschal J; Milpied B; Taieb A Chem Immunol Allergy; 2012; 97():203-16. PubMed ID: 22613864 [TBL] [Abstract][Full Text] [Related]
53. [Histopathology of cutaneous drug reactions]. Ortonne N Ann Pathol; 2018 Feb; 38(1):7-19. PubMed ID: 29279184 [TBL] [Abstract][Full Text] [Related]
55. Management of drug eruptions: Part II. Diagnosis and treatment. Breathnach SM Australas J Dermatol; 1995 Nov; 36(4):187-91. PubMed ID: 8593105 [TBL] [Abstract][Full Text] [Related]
56. Severe adverse cutaneous reactions to drugs. Roujeau JC; Stern RS N Engl J Med; 1994 Nov; 331(19):1272-85. PubMed ID: 7794310 [No Abstract] [Full Text] [Related]
57. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work. Matsuda T; Ly NTM; Kambe N; Nguyen CTH; Ueda-Hayakawa I; Son Y; Okamoto H J Dermatol; 2018 Mar; 45(3):344-348. PubMed ID: 29239026 [TBL] [Abstract][Full Text] [Related]